Lung Cancer Clinical Trial
Screening Study for Participants With Malignant Tumors
The study objective is to determine the biomarker status of a participant's tumor tissue and use that status to determine eligibility for a linked Roche clinical trial.
General Inclusion Criteria:
Confirmed availability of a representative formalin-fixed, paraffin-embedded (FFPE) tumor specimen meeting criteria defined in the protocol
Considered by principal investigator (PI) to be a candidate for a linked clinical trial with an investigational medicinal product, and that the participant has the awareness and willingness to participate in said trial
Inclusion Criteria for Participants with Stage III NSCLC
Locally advanced, unresectable Stage III NSCLC of either squamous or non-squamous histology based on 8th edition of the American Joint Committee on Cancer (AJCC) and Union for International Cancer Control (UICC) cancer staging system
Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2
General Exclusion Criteria:
History of malignancy other than NSCLC within 5 years prior to screening, except for malignancies with a negligible risk of metastasis or death
Any condition that may affect the interpretation of study results
Significant liver or cardiovascular disease
Prior allogenic stem-cell or solid-organ transplantation
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 19 Locations for this study
Tucson Arizona, 85704, United States
Longmont Colorado, 80504, United States
Knoxville Tennessee, 37916, United States
Austin Texas, 78745, United States
San Antonio Texas, 78229, United States
Tyler Texas, 75702, United States
Blacksburg Virginia, 24060, United States
Vancouver Washington, 98686, United States
San José , 10103, Costa Rica
San José , 10108, Costa Rica
Hong Kong , , Hong Kong
Hyogo , 670-8, Japan
Miyagi , 980-0, Japan
Nara , 634-8, Japan
Okayama , 700-8, Japan
Okayama , 710-8, Japan
Tottori , 683-8, Japan
Daegu , 41404, Korea, Republic of
Seongnam-si , 13605, Korea, Republic of
Seoul , 08308, Korea, Republic of
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.